CC BY-NC-ND 4.0 · South Asian J Cancer 2019; 08(02): 135-136
DOI: 10.4103/sajc.sajc_7_19
Letter to Editor

Case report on stereotactic body radiation therapy for locally recurrent renal cell carcinoma after partial nephrectomy in a patient with single kidney

Kaushik Jagannath Kataki
,
Ajinkya Gupte
Department of Radiation Oncology, Amrita Institute of Medical Sciences, Kochi, Kerala
,
Ram Madhavan
Department of Radiation Oncology, Amrita Institute of Medical Sciences, Kochi, Kerala
,
K. Beena
Department of Radiation Oncology, Amrita Institute of Medical Sciences, Kochi, Kerala
,
Debnarayan Dutta
Department of Radiation Oncology, Amrita Institute of Medical Sciences, Kochi, Kerala
,
Raghavendra Holla
Department of Radiation Physics, Amrita Institute of Medical Sciences, Kochi, Kerala
,
Manoj Kalita
Department of Biostatistics, Dr. B. Borooah Cancer Institute, Guwahati, Assam
› Author Affiliations
Financial support and sponsorship: Nil.


Publication History

Publication Date:
21 December 2020 (online)

© 2019. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Bratslavsky G, Linehan WM. Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol 2010;7:267-75.
  • 2 Acar Ö, Şanlı Ö. Surgical management of local recurrences of renal cell carcinoma. Surg Res Pract 2016;2016:2394942.
  • 3 Bhat S. Role of surgery in advanced/metastatic renal cell carcinoma. Indian J Urol 2010;26:167-76.
  • 4 Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.